Description
A liquid biopsy with a 52-gene panel analyzes circulating tumor DNA (ctDNA) from a blood sample to identify specific genetic mutations associated with cancer. This non-invasive test helps in diagnosis, treatment selection, and monitoring cancer progression.
Reviews
There are no reviews yet.